Literature DB >> 29227292

Association of hyperglycemia, systolic and diastolic hypertension, and hyperthermia relative to baseline in the acute phase of stroke with poor outcome after intravenous thrombolysis.

Stefano Forlivesi1, Nicola Micheletti, Giampaolo Tomelleri, Paolo Bovi, Manuel Cappellari.   

Abstract

: In the acute phase of ischemic stroke, the trend of some physiological variables, such as blood glucose (BG), blood pressure, and body temperature (BT), might influence outcome. We aimed to assess the association of hyperglycemia, systolic and diastolic hypertension, and hyperthermia relative to baseline BG, systolic blood pressure, diastolic blood pressure and BT, respectively, in the first 12 h with poor outcome after intravenous thrombolysis (IVT). We conducted a retrospective analysis of data prospectively collected from 200 consecutive anterior ischemic stroke patients treated with IVT. Outcome measures were no neurological improvement at 24 h (National Institutes of Health Stroke Scale (NIHSS) score at 24 h ≥NIHSS score at baseline), and unfavorable functional outcome [modified Rankin Scale (mRS) score 3-6] at 3 months. No neurological improvement at 24 h was noted in 52 (26%) patients and mRS 3-6 at 3 months in 68 (34%) patients. The multivariate analyses showed that odds ratios (ORs) for no neurological improvement at 24 h were higher in patients with hyperglycemia relative to baseline [OR 3.50, 95% confidence interval (CI) 1.43-8.57, P = 0.006], and hyperthermia relative to baseline (OR 2.88, 95% CI 1.20-6.91, P = 0.018). OR for 3-month mRS score 3-6 was higher in patients with hyperthermia relative to baseline (OR 3.05, 95% CI 1.20-7.74, P = 0.019). Hyperglycemia and hyperthermia relative to baseline in the first 12 h after IVT are associated with no neurological improvement at 24 h. Hyperthermia relative to baseline is also associated with unfavorable functional outcome at 3 months.

Entities:  

Mesh:

Year:  2018        PMID: 29227292     DOI: 10.1097/MBC.0000000000000689

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  5 in total

Review 1.  Clinical Variables and Genetic Risk Factors Associated with the Acute Outcome of Ischemic Stroke: A Systematic Review.

Authors:  Nuria P Torres-Aguila; Caty Carrera; Elena Muiño; Natalia Cullell; Jara Cárcel-Márquez; Cristina Gallego-Fabrega; Jonathan González-Sánchez; Alejandro Bustamante; Pilar Delgado; Laura Ibañez; Laura Heitsch; Jerzy Krupinski; Joan Montaner; Joan Martí-Fàbregas; Carlos Cruchaga; Jin-Moo Lee; Israel Fernandez-Cadenas
Journal:  J Stroke       Date:  2019-09-30       Impact factor: 6.967

2.  Baseline blood pressure does not modify the effect of intravenous thrombolysis in successfully revascularized patients.

Authors:  Zhang Xiaoxi; Zhu Xuan; Zhang Lei; Li Zifu; Xing Pengfei; Shen Hongjian; Zhang Yongxin; Hua Weilong; Zhou Yihan; Dai Dongwei; Li Qiang; Zhao Rui; Huang Qinghai; Xu Yi; Lili Song; Craig S Anderson; Liu Jianmin; Zhang Yongwei; Yang Pengfei
Journal:  Front Neurol       Date:  2022-09-12       Impact factor: 4.086

3.  Soluble Epoxide Hydrolase Blockade after Stroke Onset Protects Normal but Not Diabetic Mice.

Authors:  Catherine M Davis; Wenri H Zhang; Elyse M Allen; Thierno M Bah; Robert E Shangraw; Nabil J Alkayed
Journal:  Int J Mol Sci       Date:  2021-05-21       Impact factor: 5.923

4.  Effects of hypertension in patients receiving mechanical thrombectomy: A meta-analysis.

Authors:  Zhengzhou Yuan; Ning Chen; Muke Zhou; Jian Guo; Yanan Zhang; Yanbo Li; Li He
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

5.  CO2 combining power and outcomes in patients with acute ischaemic stroke or transient ischaemic attack.

Authors:  Anxin Wang; Xue Tian; Hongqiu Gu; Yingting Zuo; Xia Meng; Wei Lv; Hao Li; Yongjun Wang
Journal:  Stroke Vasc Neurol       Date:  2020-12-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.